SCHEMBL25263181

SCHEMBL25263181

CON(C)C(=O)c1cc(F)c(Br)cc1N

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 2/20 0.35
MTOR P42345 2/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
MLYCD O95822 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
POLB P06746 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALDH1A1 P00352 3/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
KDM4E B2RXH2 3/20 0.32
TRPM8 Q7Z2W7 1/20 0.32
LMNA P02545 1/20 0.32
TSHR P16473 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
SOS1 Q07889 1/20 0.31
CLK1 P49759 1/20 0.31
DYRK1A Q13627 1/20 0.31
DYRK1B Q9Y463 1/20 0.31
CFTR P13569 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21494356 0.94 PIK3CA (0.37) PIK3CAMTORMEN1KMT2AMLYCD
SCHEMBL18075678 0.86 KMT2A (0.36) PIK3CAMTORMEN1KMT2AMLYCD
SCHEMBL31103821 0.83 KMT2A (0.36) PIK3CAMTORMEN1KMT2AMLYCD
SCHEMBL21050898 0.82 MEN1 (0.46) PIK3CAMTORMEN1KMT2ATDP1
SCHEMBL20139638 0.80 MLYCD (0.37) PIK3CAMTORMEN1KMT2AMLYCD
SCHEMBL30845490 0.80 MLYCD (0.37) PIK3CAMTORMEN1KMT2AMLYCD
SCHEMBL1551558 0.79 MEN1 (0.43) PIK3CAMTORMEN1KMT2AMLYCD
SCHEMBL16858435 0.78 KDM4E (0.54) POLBALDH1A1KDM4ELMNATSHR
SCHEMBL6745164 0.77 MEN1 (0.35) PIK3CAMTORMEN1KMT2AMLYCD
SCHEMBL21494414 0.76 MLYCD (0.36) PIK3CAMTORMEN1KMT2AMLYCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023107870-A1 INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES KINNATE BIOPHARMA INC. (US) 2023-06-15 WO disclosed